The treatment of systemic mycoses.
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D011193:Potassium Iodide / Q000627:therapeutic use; D013266:Stilbamidines / Q000627:therapeutic use
D000935:Antifungal Agents; D013266:Stilbamidines; D011193:Potassium Iodide; D000666:Amphotericin B; D005437:Flucytosine